Aceneuramic acid
- Generic Name
- Aceneuramic acid
- Drug Type
- Small Molecule
- Chemical Formula
- C11H19NO9
- CAS Number
- 131-48-6
- Unique Ingredient Identifier
- GZP2782OP0
- Background
Aceneuramic acid has been used in trials studying the treatment of Distal Myopathy, Nonaka Type, Hereditary Inclusion Body Myopathy, and Distal Myopathy With Rimmed Vacuoles.
Efficacy Confirmation Study of NPC-09
Phase 3
Completed
- Conditions
- Distal Myopathy With Rimmed Vacuoles (DMRV)Hereditary Inclusion Body Myopathy (hIBM)GNE MyopathyNonaka Disease
- Interventions
- Drug: NPC-09 placebo
- First Posted Date
- 2020-12-17
- Last Posted Date
- 2022-05-16
- Lead Sponsor
- Nobelpharma
- Target Recruit Count
- 14
- Registration Number
- NCT04671472
- Locations
- 🇯🇵
National Center Hospital of Neurology and Psychiatry Hospita, Kodaira, Tokyo, Japan
🇯🇵Kumamoto University Hospital, Kumamoto, Japan
🇯🇵Nagoya University Hospital, Nagoya, Aichi, Japan
Pharmacokinetic Study on N-acetylneuraminic Acid
Phase 1
Completed
- Conditions
- Nonaka MyopathyHereditary Inclusion Body Myopathy
- Interventions
- First Posted Date
- 2010-11-09
- Last Posted Date
- 2011-09-08
- Lead Sponsor
- Tohoku University
- Target Recruit Count
- 6
- Registration Number
- NCT01236898
- Locations
- 🇯🇵
Tohoku University Hospital, Sendai, Miyagi, Japan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath